Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2025-12-25 @ 11:18 PM
Study NCT ID:
NCT05893693
Status:
RECRUITING
Last Update Posted:
2023-06-08
First Post:
2023-04-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Sponsor:
Aibin Liang，MD，Ph.D.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-12
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-04
First Submit QC Date:
None
Study First Post Date:
2023-06-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-29
Last Update Post Date:
2023-06-08
Last Update Post Date Type:
ACTUAL